Security key
501575104
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)
CUSIP: 501575104
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 81,496,373
- Total 13F shares
- 72,808,716
- Share change
- +1,093,234
- Total reported value
- $1,995,263,098
- Put/Call ratio
- 108%
- Price per share
- $27.37
- Number of holders
- 171
- Value change
- +$5,348,226
- Number of buys
- 84
- Number of sells
- 85
Report period
Q1 2025
Institutions
171
Top holders
10
KYMR full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Kymera Therapeutics, Inc. SEC filings
Kymera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501575104
Recent filing periods:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.4%
|
6,870,333
|
$276,395,000 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
7.4%
|
5,995,929
|
$241,216,224 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.5%
|
5,307,326
|
$213,513,725 | — | 31 Dec 2024 | |
| BVF INC/IL |
13F
|
Company |
6.3%
|
5,161,801
|
$207,659,254 | — | 31 Dec 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.3%
|
5,150,000
|
$207,184,500 | — | 31 Dec 2024 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
6%
|
4,896,462
|
$196,984,666 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6%
|
4,887,312
|
$196,616,562 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
5.9%
|
4,830,423
|
$194,327,918 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.3%
|
4,356,303
|
$175,254,068 | — | 31 Dec 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
3.6%
|
2,969,733
|
$119,472,359 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,688,789
|
$67,939,981 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,390,372
|
$55,934,666 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,105,487
|
$44,483,666 | — | 31 Dec 2024 | |
| Redmile Group, LLC |
13F
|
Company |
1.4%
|
1,100,432
|
$44,270,379 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.3%
|
1,034,137
|
$41,603,332 | — | 31 Dec 2024 | |
| Merck & Co., Inc. |
13F
|
Company |
0.95%
|
772,165
|
$31,064,198 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.88%
|
716,933
|
$28,842,214 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.73%
|
593,000
|
$23,856,390 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.66%
|
537,428
|
$21,620,728 | — | 31 Dec 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.61%
|
500,000
|
$20,115,000 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.58%
|
469,842
|
$18,901,743 | — | 31 Dec 2024 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
0.56%
|
457,059
|
$18,387,484 | — | 31 Dec 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
455,728
|
$18,333,937 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
437,833
|
$17,614,022 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.53%
|
433,944
|
$17,457,567 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.53%
|
433,755
|
$17,446,788 | — | 31 Dec 2024 | |
| Boxer Capital Management, LLC |
13F
|
Company |
0.52%
|
425,000
|
$17,097,750 | — | 31 Dec 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.51%
|
419,490
|
$16,876,083 | — | 31 Dec 2024 | |
| Deer Management Co. LLC |
13F
|
Company |
0.51%
|
415,895
|
$16,731,456 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.5%
|
404,667
|
$16,279,754 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
387,187
|
$15,576,533 | — | 31 Dec 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.47%
|
383,310
|
$15,420,561 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.46%
|
377,384
|
$15,197,254 | — | 31 Dec 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.43%
|
350,000
|
$14,080,500 | — | 31 Dec 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.4%
|
326,349
|
$13,129,020 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.32%
|
260,300
|
$10,471,869 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.29%
|
239,763
|
$9,645,674 | — | 31 Dec 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.28%
|
228,560
|
$9,194,969 | — | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.26%
|
215,480
|
$8,668,760 | — | 31 Dec 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.23%
|
183,521
|
$7,383,050 | — | 31 Dec 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.22%
|
176,220
|
$7,089,330 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
173,753
|
$6,990,083 | — | 31 Dec 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.2%
|
163,896
|
$6,444,391 | — | 31 Dec 2024 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.18%
|
150,172
|
$6,041,420 | — | 31 Dec 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.18%
|
147,296
|
$5,925,718 | — | 31 Dec 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
147,238
|
$5,923,385 | — | 31 Dec 2024 | |
| Foresite Capital Management VI LLC |
13F
|
Company |
0.18%
|
146,332
|
$5,886,936 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
143,225
|
$5,761,941 | — | 31 Dec 2024 | |
| Atika Capital Management LLC |
13F
|
Company |
0.17%
|
136,500
|
$5,491,396 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
127,093
|
$5,112,953 | — | 31 Dec 2024 |
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q1 2025
As of 31 Mar 2025,
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,808,716 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BVF INC/IL, Atlas Venture Life Science Advisors, LLC, FMR LLC, BlackRock, Inc., and Siren, L.L.C..
This page lists
172
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
177
Q1 2025 holders
171
Holder diff
-6
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.